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abstract

This research was developed in order to identify factors
contributing to medication non-adherence in congestive heart
failure patients. In a pilot study completed at a community
pharmacy in a small midwestern town, pharmacists completed
paper surveys regarding their consultations with congestive
heart failure patients. Information noted by the pharmacists
included patient questions, drug-related problems discovered,
patient gender, refill versus new prescription, and patient age.
Questions asked most frequently involved cost or financial
concerns (15.4% of patients, n = 4) and dosage amount
(11.5% of patients, n = 3). All patients obtaining a new
prescription had questions as compared to 42.9% of patients
(n = 11) refilling a prescription. Future developments may
include surveys seeking more descriptive accounts of
consultations, researcher interviews with pharmacists,
and extension of the study to additional pharmacy sites.
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IntRoDuCtIon
Fear depends on how a person perceives risk. For
example, it seems that everyone has a friend who is
afraid of flying. Perhaps that friend is you. In a sense,
fear of flying is completely rational; nothing violates the
perception of safety quite like catapulting through the sky
in a metal tube at speeds reaching 600 miles per hour.
In contrast, there are also individuals who panic at the
thought of receiving a shot, donating blood, or going to
the emergency room after an accident. This type of fear
seems entirely irrational. Health care, hospitals, and visits
to the doctor are supposed to improve a person’s health
and safety. How could an individual perceive engaging in
health and wellness behaviors as a risk?
What researchers have uncovered is that a person’s
perception of risk is not always accurate. Figure 1 shows

Figure 1. Comparison of risk in health care and other
industries (Kalra, 2011).

the relative risk of various industries, categorized by lives
lost per encounter each year (Kalra, 2011). As shown,
health care has a risk comparative to bungee jumping.
Kalra points out, “Because of the complexity of health
care and the current rate of adverse events, it must be
mentioned that it cannot be compared with other highrisk industries, such as aviation and nuclear energy, both
of which boast lower levels of risk” (2011, p. 3). Health
care, in other words, is so much riskier and more complex
than other high-risk industries that it should not even be
included in the comparison.
The Institute of Medicine (IOM) released a report
that estimated between 44,000 and 98,000 people die
in hospitals each year due to medical errors (Kohn,
Corrigan, & Donaldson, 2000). This report underscored
the need to redesign our health care system in a way that
would promote error prevention. Over a decade later, it
is still unclear if efforts to improve health care safety
have succeeded. When comparing the current health
care system to the health care system at the time of the
IOM report, Robert Wachter (2010) gives patient safety
progress an overall grade of B-minus.
Medication errors are one of the primary contributors
to deaths related to medical errors. According to
research highlighted in the IOM report, nearly 2%
of hospital admissions had issues with preventable
adverse drug events (Bates et al., 1997, as cited in Kohn,
2000). Medication errors are frequently attributed to
communication breakdowns between care providers. The
patient care communication mechanism can be thought
of as a triangle (Figure 2) between patient, provider,
and pharmacist (Benedict & Caldwell, 2011). When this
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difficult disease to manage due to the relatively advanced
age of the population it afflicts and the propensity for
these patients to suffer from additional diseases that
worsen their health.

Method

Figure 2. Patient care communication triangle (Benedict &
Caldwell, 2011).

triangle of communication is incomplete or missing
information, medication errors are more likely to occur.
However, little research has been done to analyze the
pharmacist’s role in the care regimen. For example, in
2001, the National Institutes of Health awarded 37%
of their extramural budget to clinicians and 1.2% to
pharmacists (Fagan et al., 2006). Simply put, “If we wish
to further improve patient care, we need to examine
the patient-pharmacist interaction” (Guirguis &
Chewning, 2005).
The goal of this study was to analyze the interaction
between the patient and pharmacist in routine
consultations at a community pharmacy. In order to
highlight the complexity of the medication care regimen,
congestive heart failure (CHF) was chosen as a target
condition for this study. CHF can be an increasingly

To begin this effort, the author created a project
protocol and study questionnaire. A collaborative
relationship was then developed with the Medication
Safety Research Network of Indiana (Rx-SafeNet). RxSafeNet is a research network within Purdue University’s
College of Pharmacy comprised of various pharmacies
throughout the state of Indiana. They aim to improve
medication safety and enhance collaboration within
community pharmacies (Purdue University, College of
Pharmacy, 2012).
The partnership with Rx-SafeNet provided clinical
pharmacy knowledge as well as data collection sites.
Rx-SafeNet helped adapt the protocol to be feasible
for a community pharmacy setting. They also assisted
in selecting appropriate drugs to aid in targeting CHF
patients. Rx-SafeNet faculty made additional suggestions
that allowed questionnaire data to be collected without
identifiable patient information, greatly reducing patient
confidentiality concerns.
The questionnaire contained six questions regarding
aspects of pharmacist interactions with patients in a
community setting. Topics specifically addressed were:
the type of drug(s) being filled for the prescription,
patient questions, drug-related problems identified by
the pharmacist, whether it was a new prescription or a
refill, patient gender, and patient age.

Figure 3. Graphical flow for data collection.
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After receiving approval from the Purdue University
Institutional Review Board, the protocol was sent to
potential data collection locations within Rx-SafeNet.
Pharmacies within the network self-selected based on
feasibility and interest in the project. One community
pharmacy in a small midwestern town elected to
participate in the study. Members of the Rx-SafeNet team
conducted an on-site visit to ensure the feasibility of the
study design. Once the authors had completed human
subject research training modules, the inaugural project
of the Rx-SafeNet was launched.

The prescriptions filled most frequently were Lisinopril
(21.4%, n = 6), Hydrochlorothiazide (14.3%, n = 4),
and Furosemide (14.3%, n = 4). Note, the number of
medications encountered in this study was actually 28,
as two patients questioned were filling prescriptions for
two of the specified medications.

The duration of the project was four weeks. Within
the given time frame, when a prescription containing
any of the previously tagged CHF medications was
filled, the pharmacist would confirm a diagnosis of
CHF and that the person picking up the drugs was
the person listed on the prescription being filled.
Then the pharmacist would complete one of the
previously developed questionnaires regarding the
patient consultation. Special markers were placed
near the CHF medications to signal to the pharmacist
or pharmacy technician that the pharmacist must
complete a questionnaire. Completed questionnaires
were kept in a locked cabinet and mailed to the first
author on a weekly basis. Figure 3 provides a graphical
representation of the project workflow.

Overall, the pharmacist recorded that over half of the
patients (53.8%, n = 14) studied had questions regarding
their prescription. The questions asked most frequently
were regarding cost and financial concerns (15.4%,
n = 4) and dosage amount (11.5%, n = 3). Table 1 shows
a breakdown of all questions asked to the pharmacist
throughout the course of the study.

Results
Of the 26 questionnaires received, the population was
split fairly evenly between male (46.2%, n = 12) and
female (53.8%, n = 14). A large majority of the patients
were between the ages of 60 and 79 (73.1%, n = 19).

Question Type and Frequency
Question Type
No questions
Cost/financial concerns
Dosage amount
Special instructions
Basic instructions
Refills
Drug side effects
What is the drug supposed to do?
Dosage frequency
Table 1. Question type and frequency.

Frequency
12
4
3
2
1
1
1
1
1

Furthermore, all patients obtaining a new prescription
had questions for the pharmacist. By contrast, 42.3%
(n = 11) of patients obtaining a refill asked the pharmacist
questions.

A Kolmogorov-Smirnov Z-test was conducted to
determine if gender or new versus refill prescription had an
effect on whether or not the patient asked the pharmacist
a question, and a Mann-Whitney U-test was conducted to
determine if age had an effect on whether or not the patient
asked the pharmacist a question. None of the associations
proved to be statistically significant. The results indicate
that patient information, such as age, gender, and type
of prescription, did not significantly affect his or her
likelihood of asking the pharmacist questions.
Lastly, one of the most alarming findings was that,
throughout the course of the study, two potential drug
therapy problems were recorded in the questionnaires.
In one instance, the pharmacist identified a potential
adverse drug reaction, and the other event was regarding
inappropriate compliance.

Discussion
Although no statistically significant interactions were
found, a few points can be taken from this pilot study.
These points become even more telling considering
this was a small pilot study conducted at a community
pharmacy. The frequency of drug therapy problems given
the relatively small sample size is of particular concern.
As previously noted, 26 questionnaires contributed to
the dataset for this study, and these questionnaires were
sent to the author on a weekly basis. Unfortunately, the
final set of data, which contained over ten additional
questionnaires, was lost in the mail. The possible effect
of this missing data on the overall outcome is unknown.
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This study was also conducted at one pharmacy in a
small midwestern community. The study would provide
more complete results if a larger or more varied sample
had been taken. Unfortunately, only one site was deemed
suitable for data collection at the time this study was
performed.
The last and probably most unsettling point is the two drug
therapy problems that were noted. Although actual adverse
events or severe patient outcomes were not observed,
both events represented significant risks to patients. The
occurrence of two such events within one month at a single
community pharmacy highlights the importance of the
pharmacist role in the CHF patient care regimen. Further
research should be undertaken to clarify the true rate
of near-miss events where pharmacist interventions are
required to avoid potentially hazardous drug events.

Potential for Future Research
As this was only a pilot study, the potential avenues
for future research are valuable outputs of the project.
Potential points of expansion stemming from the pilot
data are described as follows:

Study Sites
New studies should attempt to gather data from multiple
pharmacies. This will not only allow analysis of different
types of pharmacies (e.g., in-hospital pharmacy vs.
community pharmacy), but also different geographical
locations (e.g., metropolitan vs. rural areas). As a whole,
varied locations will give a more accurate picture of the
general population and help limit any biases.

Additional Diseases
Using a similar rationale as the expansion to multiple
locations, additional work could also target patients with
diabetes in addition to patients with CHF. Adding another
disease will provide an opportunity for comparison and
add the possibility of examining patients who may suffer
from more than one chronic disease. Diabetes would be a
good fit due to its prevalence in the United States at this
time and because it afflicts patients of a more varied age
group than CHF.
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Adverse Drug Events
Due to the alarming frequency of drug therapy problems
in previous research, more data should be gathered to
better understand why these events occur and how they
are handled in hopes of improving methods of prevention.
Studies should attempt to find the root causes of these
events, possibly through additional interviews with
pharmacists following drug therapy problem detection.

Nonnative English-Speaking Populations
In a project completed for another course, the author
spoke with adults who were students in a beginner-level
English course regarding how they obtain and understand
prescription medication. Their initial responses were
worrisome. Two said they buy over-the-counter medicines
and receive prescriptions in English. While one said
he relied on his English skills to ask the pharmacist to
explain the instructions, the other consulted an online
dictionary to translate the instructions into her native
language. Both of these pose potentially unreliable
solutions to a high-risk situation (as even the adult relying
on his English skills was a student in a beginner-level
English course).
Given the severity of the risk associated with
misunderstanding medication instructions, it also would
be advantageous to focus efforts on understanding how
better health care access can be given to nonnative
English speakers. Further studies could be performed with
English as a second language (ESL) populations in order
to find out how they obtain and understand prescription
medication, what types of resources are available to them,
how often they obtain prescription medication, and if
language barriers have ever deterred them from getting
or filling prescriptions. Additionally, pharmacists could
document interaction with nonnative English speakers.

Tacit Information Discovery
Recent work in the area of health care information
coordination addresses the differences between explicit,
implicit, and tacit information. In order to better
understand the processes associated with this sector of
health care delivery, it would be beneficial to interview

participating pharmacists. The aim is to uncover tacit
information associated with this work domain. Although
many may synonymize tacit and implicit knowledge,
the distinction can be made in that “tacit knowledge is
information that is part of an expert’s internalized body of
knowledge” (Vallette & Caldwell, 2012, p. 1).
Another way of saying this would be that tacit knowledge
is the pharmacist’s internal or learned knowledge. For
example, a pharmacist may notice instructions for drug
“x” are often a source of confusion, so the pharmacist
asks each patient who obtains drug “x” to explain his or
her understanding of said instructions. The tacit part of
this knowledge is that drug “x” often causes confusion in
patients. This is information that may not be known by
a pharmacist who does not often see prescriptions for
drug “x.”
Pharmacists’ use of tacit knowledge, and expert
translation of tacit knowledge to explicit information,
might be especially valuable in handling and prevention
of adverse drug events. While pharmacy training develops
relevant domain knowledge, improved knowledge
sharing between pharmacists regarding patient adherence
communication difficulties can help improve translations
from domain knowledge to safe patient practice.
One way knowledge sharing could be facilitated is
through the creation of a software tool that would
allow pharmacists within a network to tag potentially
problematic drugs and include suggestions for how to
prevent issues. Obviously, these entries would need to be
screened by an internal administrator to ensure legitimacy
and accuracy. These warnings or recommendations would
then be displayed on all computers in the network when a
patient came to the pharmacy to obtain one of the tagged
drugs. Although this is merely of an example of how
tacit knowledge may be converted to explicit information
and then disseminated, it demonstrates how knowledge
sharing can aid in delivering more efficient, safer care.
Ultimately, through collaboration, the hope is to create
a system that is better at preventing and handling the
occurrence of adverse events.

Conclusions
In conclusion, regardless of the study’s sample size, there
are a few significant takeaway messages. The majority of
the patients had questions regarding their prescriptions,
and there was (surprisingly) more than one drug therapy
problem detected. Both of these serve as important
indicators of the critical role that the pharmacist plays
within the triangle of patient-physician-pharmacist
communication.
As previously mentioned, this pilot study has served
to highlight areas of this topic of patient-provider
communication that deserve further exploration. Crucial
elements to further research include the addition of
multiple, diverse study sites, expansion of diseases
studied, and a special focus on the root causes of potential
adverse drug events.
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